767 related articles for article (PubMed ID: 12975249)
1. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cardiac L-type calcium current response to beta2-adrenergic stimulation in heart failure.
Zhang ZS; Cheng HJ; Ukai T; Tachibana H; Cheng CP
J Pharmacol Exp Ther; 2001 Jul; 298(1):188-96. PubMed ID: 11408541
[TBL] [Abstract][Full Text] [Related]
3. Developmental changes in beta2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains.
Rybin VO; Pak E; Alcott S; Steinberg SF
Mol Pharmacol; 2003 Jun; 63(6):1338-48. PubMed ID: 12761344
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
Xiao RP
Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
[TBL] [Abstract][Full Text] [Related]
5. Temporal dynamics of inotropic, chronotropic, and metabolic responses during beta1- and beta2-AR stimulation in the isolated, perfused rat heart.
McConville P; Spencer RG; Lakatta EG
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E412-8. PubMed ID: 15840637
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle.
Duarte T; Menezes-Rodrigues FS; Godinho RO
J Pharmacol Exp Ther; 2012 Jun; 341(3):820-8. PubMed ID: 22438472
[TBL] [Abstract][Full Text] [Related]
7. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
[TBL] [Abstract][Full Text] [Related]
8. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart.
Zhang ZS; Cheng HJ; Onishi K; Ohte N; Wannenburg T; Cheng CP
J Pharmacol Exp Ther; 2005 Dec; 315(3):1203-11. PubMed ID: 16135702
[TBL] [Abstract][Full Text] [Related]
9. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases.
Xiao RP; Tomhave ED; Wang DJ; Ji X; Boluyt MO; Cheng H; Lakatta EG; Koch WJ
J Clin Invest; 1998 Mar; 101(6):1273-82. PubMed ID: 9502768
[TBL] [Abstract][Full Text] [Related]
10. G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels.
Chen-Izu Y; Xiao RP; Izu LT; Cheng H; Kuschel M; Spurgeon H; Lakatta EG
Biophys J; 2000 Nov; 79(5):2547-56. PubMed ID: 11053129
[TBL] [Abstract][Full Text] [Related]
11. Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression.
Danson EJ; Zhang YH; Sears CE; Edwards AR; Casadei B; Paterson DJ
Cardiovasc Res; 2005 Sep; 67(4):613-23. PubMed ID: 15936740
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
Nikolaev VO; Bünemann M; Schmitteckert E; Lohse MJ; Engelhardt S
Circ Res; 2006 Nov; 99(10):1084-91. PubMed ID: 17038640
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase offsets cAMP-mediated positive inotropic effect via inhibiting Ca2+ influx in cardiomyocytes.
Leblais V; Jo SH; Chakir K; Maltsev V; Zheng M; Crow MT; Wang W; Lakatta EG; Xiao RP
Circ Res; 2004 Dec; 95(12):1183-90. PubMed ID: 15539636
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
Devic E; Xiang Y; Gould D; Kobilka B
Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
[TBL] [Abstract][Full Text] [Related]
15. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
[TBL] [Abstract][Full Text] [Related]
17. Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.
Ziolo MT; Maier LS; Piacentino V; Bossuyt J; Houser SR; Bers DM
Circulation; 2004 Apr; 109(15):1886-91. PubMed ID: 15037528
[TBL] [Abstract][Full Text] [Related]
18. Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.
Xiao RP; Ji X; Lakatta EG
Mol Pharmacol; 1995 Feb; 47(2):322-9. PubMed ID: 7870040
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
20. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
